Can COVID-19 be associated with a higher risk of developing shingles?
Tuesday, 16 August 2022 - Tuesday, 16 August 2022
Time: 6.30PM - 8.00PM
Venue: Online
This educational webinar focuses on herpes zoster (shingles) and its prevention with SHINGRIX (Recombinant Varicella Zoster Virus glycoprotein E antigen (AS01b adjuvanted vaccine)), including a discussion on whether COVID-19 can be associated with a higher risk of developing shingles. This webinar will be presented by A/Prof Michael Woodward, including a patient case study presented by Prof Paul Bird.